Clinical trial
Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With…
NCT00003876 · Barrett Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003876 |
|---|---|
| Title | Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma |
| Official title | A Phase I Study of Concurrent Multi-modality Treatment for Patients With Relapsed Malignant Glioma Using Permanent I-125 Interstitial Seeds and Dose Escalation of Gliadel 3.85% Carmustine (BCNU) Polymer Wafers |
| Lead sponsor | Barrett Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | polifeprosan 20 with carmustine implant, surgical procedure, iodine I 125 |
| Start date | Apr 1, 1999 |
| Completion | May 1, 2004 |
| First posted | May 20, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: